[1]BioorganicandMedicinalChemistry,2000,vol.8,p.2229-2241
[1]Patent:US6685617,2004,B1.Locationinpatent:Page/Pagecolumn92
[1]JournalofMedicinalChemistry,2020,vol.63,p.3359-3369
133373-24-7
138775-48-1
162502-65-0
77128-72-4
71989-38-3
146982-30-1
1196153-01-1 | 5-ACETYLAMINO-6-AMINO-3-METHYLURACIL, HYDRATE | AA008S1N | MFCD02684004
103878-43-9 | PYRIDINE-2-CARBOXYLIC ACID (2-AMINO-ETHYL)-AMIDE | AA008S9S | MFCD05022406
104291-17-0 | 7-Deaza-4-Cl-2’-dG | AA008SIC | MFCD01631016
1210004-12-8 | JZL 195 | AA008SP9 | MFCD18382122
1028205-76-6 | 2,3,4,5,6-Pentamethylphenylboronic acid | AA008SSP | MFCD06801718
112362-50-2 | Dalfopristin | AA008T0Y | MFCD00895414
1092536-54-3 | 4-Benzyloxy-3,3-dimethylbut-1-yne | AA008TB8 | MFCD23106327
1208319-26-9 | Oclacitinib | AA008TFW | MFCD25976611
1089736-73-1 | L-Valine, N-(1-oxopentyl-d9)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]Methyl]- | AA008TKL | MFCD08063540
107485-63-2 | 2-Bromo-6-fluorobenzamide | AA008TQO | MFCD07368694